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Abstract. 
 
Previous studies have shown that polymor-
phonuclear leukocyte (PMN) adherence to endothelial 
cells (EC) induces transient increases in EC cytosolic 
 
free calcium concentration ([Ca
 
2
 
1
 
]
 
i
 
) that are required for 
PMN transit across the EC barrier (Huang, A.J., J.E. 
Manning, T.M. Bandak, M.C. Ratau, K.R. Hanser, and 
 
S.C. Silverstein. 1993. 
 
J. Cell Biol.
 
 120:1371–1380). To 
determine whether stimulation of [Ca
 
2
 
1
 
]
 
i
 
 changes in EC 
by leukocytes was induced by the same molecules that 
mediate leukocyte adherence to EC, [Ca
 
2
 
1
 
]
 
i
 
 was mea-
sured in Fura2-loaded human EC monolayers. Expres-
sion of adhesion molecules by EC was induced by a pre-
treatment of the cells with histamine or with 
 
Escherichia 
coli
 
 lipopolysaccharide (LPS), and [Ca
 
2
 
1
 
]
 
i
 
 was measured 
in single EC after the addition of mAbs directed against 
the EC adhesion proteins P-selectin, E-selectin, intercel-
lular adhesion molecule-1 (ICAM-1), vascular cell adhe-
sion molecule-1 (VCAM-1), or platelet/endothelial cell
adhesion molecule-1 (PECAM-1). Both anti–P- and 
anti–E-selectin mAb, as well as anti–VCAM-1 mAb, in-
duced transient increases in EC [Ca
 
2
 
1
 
]
 
i
 
 that were compa-
rable to those induced by 200 
 
m
 
M histamine. In contrast, 
no effect was obtained by mAbs directed against the 
endothelial ICAM-1 or PECAM-1. PMN adherence di-
rectly stimulated increases in [Ca
 
2
 
1
 
]
 
i
 
 in histamine- or 
LPS-treated EC. mAbs directed against leukocyte CD18 
or PECAM-1, the leukocyte counter-receptors for endo-
thelial ICAM-1 and PECAM-1, respectively, did not in-
hibit PMN-induced EC activation. In contrast, mAb di-
rected against sialyl Lewis x (sLe
 
x
 
), a PMN ligand for 
endothelial P- and E-selectin, completely inhibited EC 
stimulation by adherent PMN. Changes in EC [Ca
 
2
 
1
 
]
 
i
 
 
were also observed after adherence of peripheral blood 
monocytes to EC treated with LPS for 5 or 24 h. In these 
experiments, the combined addition of mAbs to sLe
 
x
 
 
and VLA-4, the leukocyte counter-receptor for endo-
thelial VCAM-1, inhibited [Ca
 
2
 
1
 
]
 
i
 
 changes in the
5 h–treated EC, whereas the anti–VLA-4 mAb alone 
was sufficient to inhibit [Ca
 
2
 
1
 
]
 
i
 
 changes in the
24 h-treated EC. Again, no inhibitory effect was ob-
served with an anti-CD18 or anti–PECAM-1 mAb. Of 
note, the conditions that induced changes in EC [Ca
 
2
 
1
 
]
 
i
 
, 
i.e., mAbs directed against endothelial selectins or 
VCAM-1, and PMN or monocyte adhesion to EC via se-
lectins or VCAM-1, but not via ICAM-1 or PECAM-1, 
also induced a rearrangement of EC cytoskeletal mi-
crofilaments from a circumferential ring to stress fibers. 
We conclude that, in addition to their role as adhesion 
receptors, endothelial selectins and VCAM-1 mediate 
endothelial stimulation by adhering leukocytes.
Key words: endothelial • adherence • signaling • se-
lectin • VCAM-l
 
he
 
 process of leukocyte extravasation at sites of in-
flammation involves two main events: (
 
1
 
) adherence
of circulating leukocytes to the endothelial wall of
post-capillary venules, and (
 
2
 
) passage (diapedesis) of leuko-
cytes across the endothelium. Endothelial cells (ECs)
 
1
 
 play
an active role in both events. Signals generated at the in-
flammatory site induce expression of endothelial adhesion
molecules that promote leukocyte rolling and sticking, and
expression by EC of various combinations of adhesion
molecules in response to particular cytokines accounts in
part for the recruitment of leukocyte subtypes during an
inflammatory or immune reaction (Bevilacqua and Nel-
son, 1993; Carlos and Harlan, 1994; Austrup et al., 1997).
Leukocyte adhesion to EC is then followed by leukocyte
penetration at inter-endothelial cell junctions, thus permit-
ting leukocyte migration into the subendothelial space.
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Hixenbaugh et al. (1997) reported that neutrophil adhe-
sion to EC monolayers causes myosin light chain phosphor-
ylation and generation of isometric tension in the mono-
layers. Since myosin phosphorylation was associated with
the formation of gaps between neighboring EC (Garcia et
al., 1995), it was proposed that leukocyte adherence to en-
dothelial cells triggers intracellular signals that, in turn,
lead to opening of the junctions.
Endothelial stimulation by adhering leukocytes was in-
vestigated by Huang et al. (1993). They found that there
was a transient increase in endothelial [Ca
 
2
 
1
 
]
 
i
 
 during
transendothelial migration of polymorphonuclear leuko-
cytes (PMNs). Moreover, these authors demonstrated
that, by inducing an increase in endothelial cell [Ca
 
2
 
1
 
]
 
i
 
,
PMN were able to affect the integrity of junctions between
EC, and that rises in [Ca
 
2
 
1
 
]
 
i
 
 were required for PMN transit
across EC monolayers. Further studies confirmed that a
rise in EC [Ca
 
2
 
1
 
]
 
i
 
 may result from the adherence to EC of
PMNs and monocytes (Ziegelstein et al., 1994) and natural
killer lymphocytes (Pfau et al., 1995). As to the mecha-
nism(s) whereby leukocytes transduce signals to EC, re-
cent studies implicate leukocyte–endothelial cell adhesion
molecules. Yoshida et al. (1996) suggested that E-selectin,
an inducible endothelial adhesion molecule that binds to
complex carbohydrate ligands on leukocytes, may have a
role in outside-in signaling. Leukocyte adherence to EC
was shown to induce association of E-selectin with the en-
dothelial cytoskeleton. Similarly, cytoskeletal association
of E-selectin was observed after clustering induced by spe-
cific antibodies. Durieur-Trautmann et al. (1994) demon-
strated that clustering of intercellular adhesion molecule-1
(ICAM-1), the endothelial ligand for the leukocyte CD11/
CD18, induced tyrosine phosphorylation of cytoskeletal
proteins potentially involved in the assembly of adherence
junctions.
In an effort to analyze comprehensively the involvement
of endothelial adhesion proteins in transmembrane signal-
ing, we examined the role of E-selectin, P-selectin, ICAM-1,
vascular cell adhesion molecule-1 (VCAM-1), and plate-
let/endothelial cell adhesion molecule-1 (PECAM-1) in
mediating intracellular changes resulting from leukocyte
adherence. Because of its functional relevance in leuko-
cyte diapedesis (Huang et al., 1993), [Ca
 
2
 
1
 
]
 
i
 
 was studied.
In addition, we investigated potential rearrangements of
endothelial cytoskeleton. Dramatic changes in endothe-
lial morphology have been shown to accompany leukocyte
adherence to and migration across endothelium (Marchesi
and Florey, 1960; Furie et al., 1987). Similar changes in en-
dothelial cell shape (Laposata et al., 1982), and a typical
rearrangement of actin microfilaments from a circumfer-
ential ring to stress fibers were shown to occur in ECs ex-
posed to soluble mediators, such as thrombin (Morel et al.,
1990; Kolodney and Wysolmerski, 1992). Of note, as with
leukocyte adherence, endothelial stimulation by thrombin
was shown to produce an increase in endothelial [Ca
 
2
 
1
 
]
 
i
 
(Goligorsky et al., 1989). Therefore, we questioned whether
engagement of endothelial adhesion receptors by leuko-
cytes would provoke cytoskeletal changes similar to those
induced when thrombin binds to its receptor, and whether
these would account for changes in EC shape during leu-
kocyte diapedesis.
We show here that mAbs directed against the endothe-
lial adhesion receptors E-selectin, P-selectin, and VCAM-1,
but not ICAM-1 and PECAM-1, induce changes in EC
[Ca
 
2
 
1
 
]
 
i
 
 and formation of stress fibers. Moreover, we show
that [Ca
 
2
 
1
 
]
 
i
 
 changes and stress fiber formation induced by
the adherence of PMNs or monocytes to EC are inhibited
by mAbs directed against the leukocyte counter-receptors
for E-selectin, P-selectin, or VCAM-1, but not against the
leukocyte counter-receptors for ICAM-1 and PECAM-1.
Our results indicate that endothelial selectins and VCAM-1
function as signaling as well as adhesion receptors.
 
Materials and Methods
 
Endothelial Cells
 
Human umbilical vein endothelial cells (HUVEC) were isolated by colla-
genase treatment of the vessels as described elsewhere (Jaffe et al., 1973)
and maintained in HUVEC medium (medium 199 buffered with 10 mM
Hepes and supplemented with 20% newborn bovine serum [HyClone
Laboratories Inc., Logan, UT], 50 
 
m
 
g/ml endothelial cell growth supple-
ment [prepared from bovine brain, as described by Maciag et al., 1979], 90
 
m
 
g/ml heparin [Sigma Chemical Co., St. Louis, MO], 50 U/ml penicillin,
and 50 
 
m
 
g/ml streptomycin). For experiments, first-passage HUVEC were
grown on gelatin-coated 22-mm glass coverslips placed on the bottom of
35-mm Petri dishes. The monolayers reached confluence within 2 d, as ev-
idenced by prominent immunostaining for PECAM-1 along the cell bor-
ders (Muller et al., 1989; Albelda et al., 1990). The cells were used in as-
says at 4–8 d after plating.
 
Leukocytes
 
Human PMN were isolated from acid-citrate-dextrose (ACD)-anticoagu-
lated blood by Ficoll-Hypaque (Nycomed Pharma AS, Oslo, Norway) gra-
dient centrifugation, 3% dextran (Pharmacia Biotech AB, Uppsala, Swe-
den) sedimentation, and hypotonic saline lysis of contaminating
erythrocytes (Boyum, 1968). The entire procedure was conducted at 4
 
8
 
C.
Purified PMN were suspended in PBS (Sigma Chemical Co.) containing
1% BSA (Sigma Chemical Co.) and held on ice (
 
,
 
3 h) until use.
Human monocytes were isolated from ACD-anticoagulated blood fol-
lowing the method of Peri et al. (1990), modified as follows. After erythro-
cyte sedimentation in 1.5% dextran, the white cell–rich plasma was
washed once with PBS containing 13 mM sodium citrate and 0.5% BSA.
The cell pellet was then resuspended in isotonic Percoll (Pharmacia Bio-
tech AB) containing 13 mM sodium citrate and 0.5% BSA, pH 7.4. The
density of the Percoll suspension was 1.0635 
 
6
 
 0.0003 g/ml, as measured at
20
 
8
 
C by a DMA density meter (A. Paar, Graz, Austria), and Percoll os-
motic value was 290 
 
6 
 
2 mosM, as measured by a cryoscopic osmometer
(Osmomat 030; Gonotec, Berlin, Germany). PBS containing 0.5% BSA
was layered over Percoll and the cell suspension was centrifuged at 1,000 
 
g
 
for 20 min at 20
 
8
 
C. The cell ring formed at the PBS–Percoll interface was
collected, washed twice, and then suspended in ice-cold PBS containing
1% BSA. The resulting cell suspension contained 
 
.
 
90% (generally 95%)
monocytes, as assessed by morphology and peroxidase-staining, and cell
viability was 
 
.
 
98%, as determined by trypan blue dye exclusion. Mono-
cytes were then held on ice until use (
 
,
 
3 h).
In experiments involving a pretreatment of leukocytes with mAbs, be-
fore addition to HUVEC monolayers, PMN or monocytes were incubated
on ice in the presence of mAb (20 
 
m
 
g/ml) for at least 1 h. The cells were
then washed twice at room temperature with PBS containing 1% BSA, 5
mM glucose, and 0.7 mM CaCl
 
2
 
, resuspended in the same medium, and
immediately added to the HUVEC monolayers at a leukocyte/HUVEC
ratio of 6–8:1.
 
Calcium Measurements
 
Cytosolic-free calcium ([Ca
 
2
 
1
 
]
 
i
 
) was monitored in single HUVEC by using
the fluorescent calcium probe Fura2-AM as described by Huang et al.
(1993), with minor modifications. [Ca
 
2
 
1
 
]
 
i
 
 measurements were performed
on a digital fluorescence-imaging microscopy system built around a Zeiss
Axiovert 135 (Oberkochen, Germany) as already described (Lorenzon et
al., 1997). The excitation light at 340 and 380 nm was provided by a modi-
fied dual wavelength microfluorimeter (CAM-230; Jasco Intl. Co. Ltd.,
Tokyo, Japan) and the fluorescence images were collected by a low light 
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level CCD camera (Hamamatsu Photonics, Hamamatsu, Japan). The
camera output was fed into a digital image processor where video frames
were digitized and integrated at real time. The image acquisition was per-
formed at two frames/s. Determination of ratio and [Ca
 
2
 
1
 
] calculation
were performed pixel by pixel on pairs of corresponding 340 and 380 im-
ages according to Grynkiewicz et al. (1985). R
 
max
 
 and R
 
min
 
 were deter-
mined using ionomycin (40 
 
m
 
M) with calcium (30 mM) or a stoichiometric
excess of EGTA, respectively. Thus, R
 
max
 
 represented the ratio of 340 nm/
380 nm signal under saturating conditions of calcium, whereas R
 
min
 
 repre-
sented the same ratio in the absence of calcium. Values used for calibra-
tion included R
 
max
 
 
 
5 
 
650, R
 
min
 
 
 
5 
 
200, 
 
K
 
d
 
 
 
5 
 
224 nM, and f380
 
min
 
/f380
 
max
 
(ratio of fluorescence at high calcium to that at low calcium) 
 
5 
 
2.
 
 
 
Tempo-
ral plots were calculated from ratio images and each temporal plot indi-
cated the mean value of variation of the fluorescent signal at the single cell
level.
Endothelial monolayers grown for 3–5 d on gelatin-coated glass cover-
slips were loaded with 5 
 
m
 
M Fura2-AM (Sigma Chemical Co.) for 30 min.
Cell loading was performed at room temperature to avoid compartmen-
talization of the dye. The monolayers were then washed twice and incu-
bated in Hepes (10 mM) buffered medium 199 supplemented with 20%
newborn bovine serum (M199-H/NBS) for an additional 20 min at room
temperature to allow de-esterification of Fura2-AM. For experiments in-
volving a pretreatment of the cells with 
 
Escherichia coli
 
 lipopolysaccha-
ride (LPS), the monolayers were first incubated for 5 or 24 h at 37
 
8
 
C with
0.5 
 
m
 
g/ml LPS, and then loaded with Fura2, as described above. Tissue
culture dishes were then mounted on the temperature-monitored stage of
the Axiovert 135, and bathed with M199-H/NBS. To minimize spontane-
ous [Ca
 
2
 
1
 
]
 
i
 
 spiking by HUVEC during the assay, the monolayers were
maintained at 37
 
8
 
C for 30 min before starting [Ca
 
2
 
1
 
]
 
i
 
 recordings. When in-
dicated, the cells were further incubated 5 min in the presence of hista-
mine (50 
 
m
 
M), washed three times with prewarmed M199-H/NBS me-
dium, and then incubated in the same medium for another 5 min at 37
 
8
 
C.
The homogeneous distribution of the fluorescent dye was carefully
checked before starting [Ca
 
2
 
1
 
]
 
i
 
 recordings. Agonists (mAbs or leuko-
cytes) were pipetted onto the monolayers 2–3 min after starting the re-
cordings, and HUVEC [Ca
 
2
 
1
 
]
 
i
 
 was then monitored for 15 min unless oth-
erwise indicated. As a control of variability among HUVEC, a maximal
increase in HUVEC [Ca
 
2
 
1
 
]
 
i
 
 (Jacob et al., 1988) was induced by the addi-
tion of 200 
 
m
 
M histamine by the end of each recording. By calculating the
ratio between the integral value of the area covered by [Ca
 
2
 
1
 
]
 
i
 
 spike(s)
and the level of the spike induced by histamine, a numeric value was ob-
tained for each cell. This value allowed to compare changes in HUVEC
[Ca
 
2
 
1
 
]
 
i
 
 obtained under different experimental conditions.
 
Immunofluorescence
 
HUVEC for immunofluorescence assay were grown on gelatin-coated
glass coverslips following the same procedure used to prepare the cells for
[Ca
 
2
 
1
 
]
 
i
 
 measurements. Since preliminary experiments indicated that en-
dothelial stress fibers almost completely disappeared in long-term cul-
tures, we performed these assays on monolayers grown for only 6–8 d af-
ter seeding. On the basis of preliminary experiments, care was also taken
to change HUVEC medium every day. When indicated, 
 
E
 
.
 
 coli
 
 LPS (0.5
 
m
 
g/ml) was present in the cell medium during the last 5 or 24 h of incuba-
tion. Agonists (mAbs or leukocytes) were then added to the monolayers
and the cells were further incubated at 37
 
8
 
C for 10 min. The monolayers
were then fixed with freshly made 3% formaldehyde (Merck, Darmstad,
Germany) in PBS for 5 min at room temperature and permeabilized with
0.5% Tx-100 (Merck) for 5 min at 0
 
8
 
C, as described by Dejana et al.
(1987). After rinsing in PBS, coverslips to be examined for actin morphol-
ogy were incubated in the presence of 0.2 
 
m
 
M fluorescein-labeled phalla-
cidin (NBD-phallacidin; Molecular Probes Europe BV, Leiden, The Neth-
erlands) in PBS for 20 min at room temperature, as suggested by the
manufacturer. In contrast, cells to be examined for PECAM-1 or ICAM-1
immunostaining were incubated for 20 min at room temperature in the
presence of fluorescein-labeled rabbit anti–mouse IgG, F(ab’)
 
2
 
 fragment.
The slides were then mounted in glycerol/PBS and observations were car-
ried out in a Zeiss Axiophot microscope equipped with epifluorescence.
Fluorescence images were recorded on Fuji N1600 professional (Fuji
Photo Film Co., Ltd., Tokyo, Japan) with a constant exposure of 40 s.
 
ELISA
 
First-passage HUVEC were plated onto gelatin-coated 96-well tissue cul-
ture plates (Costar Cluster, Cambridge, MA) and grown to confluence in
HUVEC medium. Histamine (50 mM) or LPS (0.5 mg/ml) or medium was
then added to the monolayers, and the cells were further incubated at
378C for the indicated time periods. The monolayers were then washed
with a three-well volumes of medium and treated for 1 h at 48C with mAbs
to adherence molecules (5 mg/ml). For the detection of P-selectin, the cells
were fixed with 1% PFA in PBS for 15 min at room temperature in the
dark before exposure to the relevant mAb. The cell monolayers were then
washed three times with PBS containing 1% BSA, incubated for 1 h at 48C
in the presence of alkaline phosphatase–labeled affinity-purified antibod-
ies from goat to mouse IgG (Sigma Chemical Co.), and further washed
three times with PBS containing 1% BSA. The reaction product was gen-
erated by the addition of para-nitrophenyl-phosphate (Sigma Chemical
Co.) at the concentration of 1 mg/ml in 0.1 M glycine buffer, pH 10.4, con-
taining 1 mM MgCl2 as substrate for the enzyme. Quantification of reac-
tion product was performed in a Multiscan 340 apparatus (Flow Laborato-
ries Inc., Milan, Italy) at 405 nm.
Adherence Assay
First-passage HUVEC were plated onto gelatin-coated 96-well tissue cul-
ture plates (Costar Cluster) and grown to confluence in HUVEC medium.
LPS (0.5 mg/ml) or medium was then added to the monolayers, and the
cells were further incubated for 24 h at 378C. Subsequently, the monolay-
ers were washed with three-well volumes of medium and untreated mono-
cytes, or monocytes that were pretreated for 60 min with mAb (20 mg/ml),
were added to the monolayers (70 ml/well). Monocytes and HUVEC were
then incubated for 15 min at 378C. After incubation, the monolayers were
washed with a two-well volume of PBS to remove non-adherent mono-
cytes. A colorimetric assay was then used to detect the leukocytes adher-
ing to the monolayers with tetramethyl benzidine (Sigma Chemical Co.)
as the peroxidase substrate, as described previously in detail (Dobrina et
al., 1991).
Antibodies
Anti–P-selectin/CD62P mAb CBL474 and anti–E-selectin/CD62E mAb
CBL180 were from Cymbus Bioscience Ltd. (Southampton, UK). Anti–
ICAM-1/CD54 mAb RR1/1 (Dustin et al., 1986) was obtained through the
courtesy of R. Rothlein (Boehringer Ingelheim, Ridgefield, CT) and anti–
ICAM-1/CD54 mAb MCA532 was obtained from Serotec Ltd. (Kidling-
ton, Oxford, UK). Anti–VCAM-1/CD106 mAb 4B9 is a blocking mAb
(Carlos et al., 1991). Anti–PECAM-1/CD31 mAb M89D3 inhibits leuko-
cyte migration across HUVEC monolayers (Zocchi et al., 1996). mAb 60.3
recognizes a functional epitope on CD11/CD18 (Beatty et al. 1983). mAb
CSLEX1 (Becton Dickinson, San Jose, CA) recognizes a functional
epitope on sialyl Lewis x(sLex)/CD15s. mAb HP2/1 binds to a functional
epitope on the CD49d (a chain) of leukocyte CD49d/CD29 (VLA-4) inte-
grin and was a gift of Dr. F. Sanchez Madrid (Servicio de Immunologia,
Hospital de la Princesa, Madrid, Spain; Sanchez Madrid et al., 1986). Pre-
liminary observations confirmed that mAb M89D3 inhibited PMN and
monocyte transendothelial migration and that all other mAbs used in this
study inhibited PMN and/or monocyte adherence to HUVEC. Migration
and adherence assays were performed as described previously (Dobrina et
al., 1991; Zocchi et al., 1996).
Results
mAbs Directed Against P-selectin, E-selectin,
and VCAM-1 Increase Endothelial Cytosolic Free 
Calcium Concentration
To examine the potential involvement of adhesion pro-
teins in endothelial stimulation, [Ca21]i was measured in
Fura2-loaded HUVEC. After incubation of EC in the
presence or absence of histamine or LPS, two agents
known to induce expression of adhesion molecules on
HUVEC (Schleimer and Rutledge, 1986; Lorant et al.,
1991), EC were exposed to leukocyte adherence-blocking
mAbs directed against endothelial P- and E-selectins,
ICAM-1, VCAM-1, and PECAM-1. In HUVEC stimu-
lated with agents such as histamine or thrombin, expres-
sion of P-selectin is known to peak by 10 min and return toThe Journal of Cell Biology, Volume 142, 1998 1384
baseline within 20–30 min (Hattori et al., 1989). In con-
trast, in LPS- or cytokine-activated HUVEC expression of
E-selectin is known to peak by 4–5 h and to return to base-
line within 8–12 h, while ICAM-1 and VCAM-1 peak at
5–10 h and decline by 48–72 h (Pober et al., 1986; Tedesco
et al., 1997). Finally, PECAM-1 is strongly expressed
at the intercellular junctions of unstimulated HUVEC
(Muller et al., 1989). In preliminary experiments we con-
firmed this pattern of expression of adhesion molecules in
HUVEC, by using mAb CBL474 to P-selectin, mAb
CBL180 to E-selectin, mAb RR1/1 or mAb MCA532 to
ICAM-1, mAb 4B9 to VCAM-1, and mAb M89D3 to
PECAM-1 (Fig. 1). Thereafter, we performed [Ca21]i
measurements after treatment of the cells for 5 min with
histamine or for 5 h or 24 h with LPS. As shown in Fig. 2,
the anti–P-selectin mAb induced an increase in [Ca21]i in
the histamine-treated HUVEC, but not in untreated
HUVEC. Similarly, the anti–E-selectin mAb and the anti–
VCAM-1 mAb caused [Ca21]i changes in HUVEC treated
with LPS for 5 or 24 h, but not in untreated HUVEC. No-
tably, the mAb-induced response, when present, was com-
parable in magnitude to the increase in [Ca21]i caused by
the addition of 200 mM histamine. In contrast, no change
in [Ca21]i was observed after the addition of the anti–
ICAM-1 mAb RR1/1 to HUVEC treated with LPS for 5
or 24 h or after the addition of the anti–PECAM-1 mAb to
unstimulated cells.
Further experiments with the anti–ICAM-1 mAb
MCA532 confirmed the negative results obtained with
RR1/1. The anti–PECAM-1 mAb also failed to activate
histamine-treated HUVEC or LPS-treated HUVEC. Sim-
ilarly, we were unable to induce [Ca21]i changes in HU-
VEC that were treated first with the anti–ICAM-1 mAb or
anti–PECAM-1 mAb, and then washed and incubated
with a goat anti–mouse IgG polyclonal antibody to induce
cell surface clustering of ICAM-1 or PECAM-1 (results
not shown).
Anti-sLex mAb and Anti–VLA-4 mAb Inhibit the 
Increase in HUVEC [Ca21]i Induced by the Adherence 
of PMNs and Monocytes
Previous studies have shown that PMN adherence to EC
elicits transient increases in endothelial [Ca21]i (Huang et
al., 1993; Ziegelstein et al., 1994). Having established that
stimulation of HUVEC with mAb directed against EC ad-
hesion proteins was similarly effective in causing transient
changes in the cell [Ca21]i, we investigated whether these
molecules were actually involved in the transduction of
signals generated upon PMN or monocyte adherence to
HUVEC. PMN are known to adhere to HUVEC via sLex,
CD11/CD18, and PECAM-1, counter-receptors for endo-
thelial P- and E-selectins, ICAM-1 and PECAM-1, respec-
tively. Hence, HUVEC were stimulated with histamine for
5 min to induce expression of P-selectin, or with LPS for
5 h to induce expression of E-selectin and ICAM-1.
HUVEC [Ca21]i was then monitored after the addition of
PMN to the monolayers. PMN were unable to induce
[Ca21]i changes in untreated HUVEC, but actively stimu-
lated [Ca21]i increases both in histamine- and in LPS-
treated monolayers (Fig. 3). Recordings of HUVEC
[Ca21]i were then repeated using PMN that had been pre-
incubated in the presence of an adherence-blocking mAb
directed against the sLex, CD18, or PECAM-1. As re-
ported in Table I, pretreatment of PMN with the anti-sLex
mAb (CSLEX1) led to a marked inhibition (.80%) of
their capacity to induce [Ca21]i changes in both histamine-
and LPS-treated HUVEC. In contrast, [Ca21]i changes in
histamine- and LPS-treated HUVEC were not signifi-
cantly inhibited by a pretreatment of PMN with an anti-
CD18 mAb (60.3) or an anti–PECAM-1 mAb (M89D3).
The same experimental approach was then followed to
investigate the effect of monocyte adhesion to HUVEC.
Monocytes are known to share with PMN the counter-recep-
tors for endothelial E-selectin, ICAM-1, and PECAM-1.
In addition, monocytes bind to endothelial VCAM-1 via
VLA-4. To induce the expression on HUVEC of E-selec-
tin, ICAM-1, and VCAM-1, the monolayers were treated
with LPS. E-selectin was assumed to be maximally ex-
pressed on HUVEC after 5 h of incubation with LPS,
whereas expression of ICAM-1 and VCAM-1 was as-
sumed to be induced after 24 h as well as 5 h of incubation
with LPS. The cells were then loaded with Fura2, and
[Ca21]i recordings were performed upon addition of
Figure 1. Time-course of in-
duction of P-selectin, E-selec-
tin, ICAM-1, VCAM-1, and
PECAM-1 expression by
HUVEC exposed to hista-
mine or LPS. HUVEC mono-
layers were treated with me-
dium containing 50 mM
histamine (A) or 0.5 mg/ml E.
coli LPS (B–D), or medium
alone (E). Cells were har-
vested at the indicated times
and examined for adhesion
molecule expression by
ELISA. The results are
means of duplicate samples
in a single experiment that is
representative of two similar
experiments performed with
different cell isolates.Lorenzon et al. Outside-In Signaling by Endothelial Adherence Molecules 1385
monocytes to the monolayers. As with PMN, monocytes
failed to induce [Ca21]i changes in untreated HUVEC.
However, they actively stimulated [Ca21]i changes in
HUVEC treated with LPS for 5 and 24 h (Fig. 4). Table II
shows the inhibitory effect of preincubation of monocytes
incubation with adherence-blocking mAb on their capac-
ity to stimulate [Ca21]i changes in HUVEC monolayers.
Pretreatment of monocytes with the anti-sLex mAb
CSLEX1 alone, the anti-CD18 mAb 60.3 alone, the anti–
VLA-4 mAb HP2/1 alone, the anti–PECAM-1 mAb M89D3
alone, or pretreatment of monocytes with combinations of
these anti-CD18, anti-VLA-4, and anti-PECAM-1 mAbs,
was ineffective in inhibiting monocyte-induced [Ca21]i
changes in 5 h LPS-treated HUVEC. However, [Ca21]i
changes were markedly reduced when monocytes were
pretreated with a combination of anti-sLex mAb and anti–
VLA-4 mAb. Since sLex and VLA-4 are ligands of endo-
thelial selectins and VCAM-1, respectively, it appears that
HUVEC treated with LPS for 5 h are stimulated by mono-
cytes primarily via E-selectin and VCAM-1. In HUVEC
treated with LPS for 24 h, treatment of monocytes with
mAb to sLex alone or to CD18 alone did not inhibit mono-
cyte-induced [Ca21]i changes. In contrast, pretreatment of
monocytes with the anti–VLA-4 mAb HP2/1 alone was
sufficient to inhibit strongly monocyte-induced [Ca21]i
changes in HUVEC, indicating that in this setting the
VLA-4/VCAM-1 interaction plays a major role in mono-
cyte stimulation of EC.
Finally, we addressed the question whether the results
obtained with mAb CSLEX1-treated PMN or with mAb
CSLEX1- and/or mAb HP2/1-treated monocytes could be
accounted for by some interference of these mAbs with
leukocyte binding to HUVEC, thus preventing other leu-
kocyte molecules from engaging HUVEC adhesion pro-
teins. This possibility could not be excluded in our experi-
ments with histamine-treated HUVEC, since Lorant et al.
(1991) demonstrated that PMN adherence to thrombin-
treated HUVEC was abolished by adherence-blocking
Figure 2. HUVEC [Ca21]i in re-
sponse to mAbs directed against
endothelial adhesion receptors
for leukocytes. Representative
tracings are shown of HUVEC
[Ca21]i measured in single cells
in Fura2-loaded endothelial mono-
layers. Surface expression of ad-
hesion receptors was induced by
incubating the HUVEC mono-
layers for 5 min in the presence
of histamine (50 mM) or for 5 h
or 24 h in the presence of E. coli
LPS (0.5 mg/ml). [Ca21]i was
measured for 15 min after the
addition (arrows) of the indi-
cated mAb. To control for vari-
ability among HUVEC, a maxi-
mal increase in [Ca21]i was
induced by the addition of 200
mM histamine (H) at the end of
each recording. Each curve is
representative of an average of
thirty recordings obtained in a
minimum of three independent
experiments.The Journal of Cell Biology, Volume 142, 1998 1386
mAb directed against P-selectin. In contrast, in a previous
report we showed that PMN adherence to HUVEC
treated with LPS for 4 h was only partially (by 50%) inhib-
ited by the presence of an adherence-blocking mAb di-
rected against E-selectin (Dobrina et al., 1991). Similarly,
we showed that monocyte adherence to HUVEC was only
minimally (z15%) altered in the presence of anti–E-selec-
tin mAb and/or anti–VLA-4 mAb (Carlos et al., 1991).
These observations indicate that PMN and monocytes
maintain their ability to adhere to HUVEC even in the
presence of mAbs, which interfere with the sLex/E-selectin
and/or the VLA-4/VCAM-1 pathways. As an additional
control, we studied the adherence of monocytes to HU-
VEC treated with LPS for 24 h. As shown in Fig. 5,
whereas pretreatment of monocytes with a combination of
anti-CD18 and anti–VLA-4 mAbs significantly inhibited
binding to the LPS-treated HUVEC, there was no inhibi-
tion when monocytes were pretreated with either mAb
alone. Hence, it seems unlikely that the potent inhibition
of monocyte-induced changes in HUVEC [Ca21]i by the
anti-VLA-4 mAb HP2/1 was accounted for solely by its
potential inhibitory effect on monocyte adherence.
mAbs Directed Against P-selectin,
E-selectin, and VCAM-1 Induce Changes in 
Endothelial F-Actin Distribution
Previous studies have shown that stimulation of EC with
soluble agonists such as histamine and thrombin, which in-
crease endothelial [Ca21]i, also induces rearrangements in
endothelial actin morphology. Having established that an
Figure 3. Effect of PMN adherence on HUVEC [Ca21]i. HUVEC
monolayers were treated for 5 min with medium alone or me-
dium containing 50 mM histamine, or for 5 h with medium con-
taining 0.5 mg/ml E. coli LPS. PMN were then added (arrows) to
the monolayers (PMN/HUVEC ratio 5 6–8:1) and fluorescence
changes were recorded for 15 min. To control for variability
among HUVEC, a maximal increase in [Ca21]i was induced by
the addition of 200 mM histamine (H) at the end of each record-
ing. Each curve is representative of an average of thirty record-
ings obtained in four independent experiments.
Table I. Effect of mAbs to Leukocyte Adhesion Molecules on 
PMN-induced Changes in HUVEC [Ca21]i
Percent inhibition
PMN treatment
CSLEX1
(anti-sLex)
60.3
(anti-CD18)
M89D3
(anti–PECAM-1)
60.3
1
M89D3
HUVEC treatment
Hist 5 min 86.6 6 2.1* 16.3 6 5.9 5.9 6 3.2 ND
LPS 5 h 84.5 6 5.8* 3.1 6 5.2 3.4 6 9.6 2.1 6 3.4
PMN were treated for 60 min in the presence or absence of mAb CSLEX1, mAb 60.3
and mAb M89D3 (20 mg/ml). HUVEC monolayers were treated for 5 min with 50 mM
histamine, or for 5 h with 0.5 mg/ml E. coli LPS. PMN were then added to the mono-
layers (PMN/HUVEC ratio 5 6–8:1) and fluorescence changes were recorded for 15
min in single Fura2-loaded HUVEC maintained in intact monolayers. Inhibitions were
calculated by comparing the areas delineated by fluorescence spikes induced by mAb-
treated and -untreated (control) PMN. To make recordings comparable to each other, a
maximal increase in HUVEC [Ca21]i was induced by the addition of 200 mM histamine
at the end of each recording. Results are means 6 SE of 3–4 independent experiments,
with 10–15 replicate recordings in each experiment. *P , 0.005 (paired t test). The
other results were not significantly different from control values. ND, not determined.
Figure 4. Effect of monocyte adherence on HUVEC [Ca21]i.
HUVEC monolayers were pretreated for 5 or 24 h with medium
alone or medium containing 0.5 mg/ml E. coli LPS. Monocytes
were then added (arrows) to the monolayers (monocyte/HUVEC
ratio  5  6–8:1) and fluorescence changes were recorded for 15
min. To control for variability among HUVEC, a maximal in-
crease in [Ca21]i was induced by the addition of 200 mM hista-
mine (H) at the end of each recording. Each curve is representa-
tive of an average of 30 recordings obtained in four independent
experiments.Lorenzon et al. Outside-In Signaling by Endothelial Adherence Molecules 1387
increase in HUVEC [Ca21]i results upon engagement of
endothelial P-selectin, E-selectin, and VCAM-1, we sought
evidence for a relationship between rearrangement of
cytoskeletal actin filaments and endothelial stimulation
via selectins or VCAM-1. Monolayers prepared identically
to those used for [Ca21]i measurements were treated with
E. coli LPS to induce expression of adhesion proteins. The
cells were then treated with various mAbs to adhesion mol-
ecules, fixed, permeabilized, and then stained with fluores-
cein-labeled phallacidin. Fig. 6 A illustrates the F-actin dis-
tribution in a control monolayer treated with LPS for 5 h.
Individual cells were clearly delineated by a rim of fluores-
cent staining. The central regions of the cells were devoid
of prominent filament bundles. However, rare and ran-
domly oriented actin fibers were present in some cells.
When LPS-treated HUVEC were exposed to mAb
CBL180 to E-selectin (Fig. 6 B), the rim of fluorescent
staining at the cell periphery was less distinct, and the actin
network was reorganized into thick cables mostly aligned
parallel to the long axis of the cell (stress fibers). Similar
results were obtained by treating the cells with mAb 4B9
to VCAM-1 (Fig. 6 C). Since not all of the cells responded
similarly to the stimuli, we analyzed the percentage of
stress fiber-positive and -negative cells under the various
conditions. As shown in Table III, .50% of cells were
positive for stress fibers after treatment of the monolayers
with mAb CBL 180 to E-selectin or mAb 4B9 to VCAM-1.
In contrast, we were unable to induce the appearance of
stress fibers by incubating the cells with mAb RR1/1 or
mAb MCA532 to ICAM-1, or with mAb M89D3 to
PECAM-1. Similarly, there was no evidence of stress fiber
formation when HUVEC monolayers that had not been
pretreated with LPS were exposed to any of the above
mAb to endothelial adhesion molecules or to the anti–
P-selectin mAb CBL474. Finally, treatment of the cells
with histamine to induce P-selectin expression caused for-
mation of prominent stress fibers directly, thus preventing
us from testing the effect of the anti–P-selectin mAb on
activated HUVEC.
Anti-sLex mAb and Anti–VLA-4 mAb Inhibit 
Rearrangement of Endothelial Actin Morphology 
Induced by PMN and Monocyte Adherence
We next investigated whether the adherence of PMNs or
monocytes to EC would induce changes in the organiza-
tion of endothelial cytoskeleton. Therefore, leukocytes
were added either to unstimulated HUVEC monolayers
or to monolayers that had been pretreated with E. coli
LPS to induce expression of adhesion molecules on their
surface. Fig. 7 depicts the effect of PMN–HUVEC interac-
tion on endothelial actin morphology. When PMN were
added to unstimulated HUVEC, F-actin distribution on
the periphery of EC remained unchanged and we could
not detect the appearance of stress fibers (Fig. 7 A). In
contrast, addition of PMN to monolayers that had been
Figure 5. Effect of mAbs to leukocyte adhesion mole-
cules on monocyte adherence to HUVEC. Endothe-
lial monolayers were pretreated for 24 h with medium
alone or medium containing 0.5 mg/ml E. coli LPS.
Monocytes were treated for 60 min in the presence or
absence of mAb CSLEX1, mAb 60.3, mAb HP2/1, or
mAb M89D3 (20 mg/ml). Monocytes were then added
to the monolayers (monocyte/HUVEC ratio 5 6–8:1).
Percent monocyte adherence was determined after a
15 min incubation at 378C. Values are means 6 SD of
three experiments with 3–4 replicate wells in each
experiment. *P , 0.05 (paired t test) compared with
adherence of untreated monocytes to LPS-treated
HUVEC. The other results were not significantly dif-
ferent from control values.
Table II. Effect of mAbs to the Leukocyte Adhesion Molecules on Monocyte-induced Changes in HUVEC [Ca21]i
Monocyte treatment
Percent inhibition
CSLEX1
(anti-sLex)
60.3
(anti-CD18)
HP2/1
(anti–VLA-4)
M89D3
(anti–PECAM-1)
CSLEX1
1
HP2/1
HP2/1
1
M89D3
60.3
1
HP2/1
60.3
1
M89D3
HUVEC treatment
LPS 5 h 5.7 6 8.4 1.7 6 8.6 3.1 6 5.8 1.8 6 5.8 80.1 6 7.1* 0.4 6 12.8 1.49 6 3.42 7.9 6 9.4
LPS 24 h 4.3 6 2.06 7.9 6 7.4 81.8 6 8.0* 13.9 6 12.7 ND ND ND ND
HUVEC monolayers were treated for 5 or 24 h with 0.5 mg/ml E. coli LPS. Monocytes were treated for 60 min in the presence or absence of mAb CSLEX1, mAb 60.3, mAb HP2/1,
and mAb M89D3 (20 mg/ml). Monocytes were then added to the monolayers (monocyte/HUVEC ratio 5 6–8:1) and fluorescence changes were recorded for 15 min in single
Fura2-loaded HUVEC maintained in intact monolayers. Inhibitions were calculated by comparing the areas delineated by fluorescence spikes induced by mAb-treated and
-untreated (control) monocytes. To make recordings comparable to each other, a maximal increase in HUVEC [Ca11]i was induced by the addition of 200 mM histamine at the end
of each recording. Results are means 6 SE of 3–4 independent experiments, with 10–15 replicate recordings in each experiment. *P , 0.005 (paired t test). The other results were
not significantly different from control values. ND, not determined.The Journal of Cell Biology, Volume 142, 1998 1388
pretreated for 5 h with LPS caused the formation of prom-
inent stress fibers in the large majority of the cells (Fig. 7
B). As shown in Table IV, pretreatment of PMN with the
anti-sLex mAb CSLEX1 completely abolished the capac-
ity of PMN to induce the formation of stress fibers in LPS-
treated HUVEC, thus implicating endothelial selectins in
EC stimulation. No inhibitory effect was observed with
preincubation of PMN with the anti-CD18 mAb 60.3 or
the anti–PECAM-1 mAb M89D3, suggesting that endo-
thelial ICAM-1 and PECAM-1 were not involved in this
response. Monocytes were used to explore the potential
involvement of the endothelial VCAM-1 in leukocyte–EC
interactions leading to formation of stress fibers. As in the
experiments with PMN, monocytes were first added to un-
stimulated HUVEC. Under these conditions, we found no
evidence of stress fiber formation in the monolayers (Fig.
8  A). To induce maximal expression of ICAM-1 and
VCAM-1 on the endothelial surface, the monolayers were
then incubated with LPS for 24 h. Under these conditions,
the addition of monocytes actively stimulated a reorgani-
zation of endothelial actin filaments into stress fibers (Fig.
8 B). As shown in Table IV, formation of stress fibers was
still induced by monocytes that had been pretreated with
the adherence-blocking anti-sLex mAb CSLEX1, the anti-
CD18 mAb 60.3, or the anti–PECAM-1 mAb M89D3.
However, pretreatment of monocytes with the anti–VLA-4
mAb HP2/1 prevented changes endothelial actin morphol-
ogy, thus confirming an involvement of VCAM-1 in EC
stimulation by adhering monocytes.
Discussion
Our results demonstrate a role in outside-in signaling for
endothelial P-selectin, E-selectin, and VCAM-1 adhesion
proteins. mAbs directed against these receptors induced
a rise in endothelial [Ca21]i and rearrangements of the
endothelial cytoskeleton. Moreover, adherence-blocking
mAbs directed against the leukocyte counter-receptors of
P-selectin, E-selectin, and VCAM-1 inhibited both endo-
thelial [Ca21]i changes and cytoskeletal changes induced
by the adhering PMNs or monocytes.
Yoshida et al. (1996) previously demonstrated a role for
E-selectin in outside-in signaling. They observed that clus-
tering of E-selectin on the endothelial surface caused its
anchoring to the actin cytoskeleton. In their study, treat-
Table III. Effect of mAbs to Adhesion Molecules on F-Actin Distribution in HUVEC
Stress fiber–positive HUVEC (%)
Medium (control)
CBL180
(anti–E-selectin)
4B9
(anti–VCAM-1)
RR1/1
(anti–ICAM-1)
MCA532
(anti–ICAM-1)
M89D3
(anti–PECAM-1)
CBL474
(anti–P-selectin)
Unstimulated HUVEC 15.1 6 2.1 13.1 6 2.1 6.2 6 3.1 14.1 6 1.8 11.6 6 3.6 16.1 6 2.7 15.2 6 2.7
LPS-treated HUVEC 7.3 6 1.8 58.5 6 5.6* 67.2 6 6.8* 12.9 6 4.0 14.6 6 2.7 12.3 6 2.7 ND
Endothelial monolayers were pretreated for 5 h with medium or medium containing 0.5 mg/ml E. coli LPS. mAb or medium (control) was then added to the monolayers and the
cells were incubated for 10 min at 37°C. The monolayers were then fixed and stained for F-actin. Coverslips were analyzed for HUVEC actin distribution by two observers. An av-
erage of 300–400 cells were examined on each coverslip. Values are means 6 SE of three experiments. *P , 0.01 (paired t test) compared to controls. ND, not determined.
Figure 6. Fluorescence micrographs of F-actin distribution in
HUVEC monolayers treated with mAbs directed to endothelial
adhesion receptors for leukocytes. Surface expression of adher-
ence receptors by HUVEC was induced by pretreating the cells
for 5 h with medium containing E. coli LPS (0.5 mg/ml). mAb or
medium (control) was then added to the monolayers and the cells
were incubated for 10 min at 378C. The monolayers were then
fixed and stained for F-actin. HUVEC margins are delineated by
a rim of fluorescent staining in control monolayers (A). Rare
actin filaments appear within the cytoplasm. In contrast, a promi-
nent network of actin filaments occupies the cytoplasm of mono-
layers treated with anti–E-selectin mAb (CBL180) (B), and anti–
VCAM-1 mAb (4B9) (C). Bar, 10 mm.Lorenzon et al. Outside-In Signaling by Endothelial Adherence Molecules 1389
ment of HUVEC with a mAb to a functional epitope in
the extracellular domain was not alone sufficient to cause
association of E-selectin with the cytoskeleton; cross-link-
ing by a secondary polyclonal antibody was required. In
contrast, by using another adherence-blocking mAb
(CBL180) to E-selectin, we were able to induce [Ca21]i
changes and formation of stress fibers in HUVEC without
a secondary cross-linking antibody. These results suggest
that the outside-in signaling function of E-selectin leading
to [Ca21]i changes and formation of stress fibers is not
linked to its association to the cytoskeleton. Moreover,
our results establish the participation of the E-selectin
epitope recognized by mAb CBL180 in outside-in signal-
ing. Similarly, the leukocyte adherence-blocking mAbs to
P-selectin (mAb CBL474) and VCAM-1 (mAb 4B9) were
by themselves effective in triggering endothelial [Ca21]i
changes and formation of stress fibers, indicating that they
identify functional epitopes in outside-in signaling. It is im-
portant to note that virtually all leukocyte populations are
endowed with adherence mechanisms recognizing E-selec-
tin, P-selectin, or VCAM-1 (Carlos and Harlan, 1994),
thus emphasizing the potential role of outside-in signaling
by these receptors in regulating the leukocyte traffic
across the endothelial barrier. It is also worth noting that
the overlapping function of P- and E-selectin with respect
to outside-in signaling is consistent with recent observa-
tions in gene-targeted animals with E- and/or P-selectin
deficiency. Neutrophil extravasation into inflamed perito-
neum was minimally altered in either the P- or the E-defi-
cient mice, whereas it was markedly reduced in animals
deficient in both selectins (Frenette et al., 1996; Munoz et
al., 1997; Subramaniam et al., 1997).
Huang et al. (1993) were the first to demonstrate that
leukocyte adherence to HUVEC induced a transient in-
crease in endothelial [Ca21]i. Since [Ca21]i changes were
induced by leukocytes equally well in the presence and in
the absence of serum, these authors concluded that oxi-
dants and/or proteases secreted by leukocytes were un-
likely to be the effectors of endothelial stimulation.
Rather, they noted that the changes in endothelial [Ca21]i
coincided temporally with leukocyte transit across the en-
dothelial monolayers, suggesting that endothelial stimula-
tion was due in part to adhesive interactions of endothelial
cells with diapedesing leukocytes. Recently, Muller et al.
(1993) demonstrated that the homophilic interaction of
leukocyte and endothelial PECAM-1 is crucial to the pro-
cess of PMN and monocyte migration through intercellu-
lar junctions of endothelial cells. Therefore, in investigat-
ing the potential involvement of adhesion molecules in
endothelial activation by leukocytes we expected that
PECAM-1 would be involved. However, treatment of
HUVEC with the anti–PECAM-1 mAb M89D3, which in-
hibits leukocyte migration across HUVEC monolayers
(Zocchi et al., 1996), did not cause [Ca21]i changes nor in-
duce the formation of stress fibers. In addition, endothelial
[Ca21]i changes and the formation of stress fibers induced
by the addition of PMN and monocytes to the EC mono-
layers were not inhibited by a pretreatment of the leuko-
cytes with mAb M89D3. Since changes in surface expres-
sion of PECAM-1 were described in HUVEC exposed to
various cytokines (Ferrero et al., 1996; Rival et al., 1996),
we also tested the anti–PECAM-1 mAb on LPS-treated
HUVEC, but again observed no effect. Similarly, negative
results were obtained when clustering of PECAM-1 was
induced by a secondary antibody. Nevertheless, we cannot
exclude a potential contribution of PECAM-1 to signaling
since: (1) the epitope recognized by M89D3, although
functionally relevant in leukocyte–HUVEC adhesive in-
teractions, might be distinct from the epitope(s) involved
in outside-in signaling, and (2) the stimulation of the EC
monolayers by PMN or monocytes pretreated with the
anti–PECAM-1 mAb is likely dependent upon the interac-
Figure 7. Fluorescence micrographs of HUVEC
F-actin distribution in the presence of PMN. Be-
fore the assay, HUVEC monolayers were treated
at 378C for 5 h with medium alone (A) or me-
dium containing 0.5 mg/ml E. coli LPS (B). PMN
were then incubated with HUVEC for 10 min at
378C. PMN adherence caused the appearance of
actin filaments in the cytoplasm of LPS-treated
HUVEC. Bar, 10 mm.
Figure 8. Fluorescence micrographs of HUVEC
F-actin distribution in the presence of mono-
cytes. Before the assay, HUVEC monolayers
were pretreated at 378C for 24 h with medium
alone (A) or medium containing 0.5 mg/ml E. coli
LPS (B). Monocytes were then incubated with
HUVEC for 10 min at 378C. Monocyte adher-
ence causes the appearance of actin bundles in
the cytoplasm of LPS-treated HUVEC. Mono-
cytes adherent to HUVEC were also detected by
F-actin staining. Bar, 10 mm.The Journal of Cell Biology, Volume 142, 1998 1390
tion of the leukocytes with endothelial receptors other
than PECAM-1 (e.g., selectins and/or VCAM-1), thereby
obscuring any effect of the leukocyte pretreatment.
In contrast to PECAM-1, the inhibitory effect of leuko-
cyte pretreatment with the anti-sLex or anti–VLA-4 mAb
provides convincing evidence for the participation of their
endothelial counter-structures in outside-in signaling. No-
tably, these treatments did not inhibit leukocyte adher-
ence to HUVEC by the CD11/CD18–ICAM-1 adherence
mechanism, nor leukocyte diapedesis. Regardless, with
these mAbs leukocytes were unable to induce [Ca21]i
changes or formation of stress fibers in the endothelial
monolayers, thus excluding any major role in [Ca21]i sig-
naling for PECAM-1 as well as for other molecules at the
inter-endothelial junctions. A recent report by Gurub-
hagavatula et al. (1998) showed that an anti–PECAM-1
antibody (mAb 4G6) induced a slow but sustained in-
crease in HUVEC [Ca21]i. Notably, the kinetics of the re-
sponses to mAb 4G6 were quite different from those in-
duced by thrombin. In contrast, in all published reports to
date, leukocyte adherence was shown to induce rapid,
large changes in HUVEC [Ca21]i, comparable to those in-
duced by agents such as histamine or thrombin. Hence, the
study by Gurubhagavatula et al. (1998) supports our con-
tention that endothelial molecules other than PECAM-1
function as signaling receptors for adhering leukocytes.
Since anti-PECAM antibodies inhibit leukocyte migration
across EC at the level of the junctions (Muller et al., 1993),
our results suggest that changes in endothelial [Ca21]i and
actin morphology are necessary, but not sufficient, to facil-
itate leukocyte diapedesis.
Four groups of investigators already investigated the in-
volvement of ICAM-1, the endothelial ligand for CD11a/
CD18 and CD11b/CD18, in endothelial outside-in signal-
ing. Durieur-Trautmann et al. (1994) reported that cluster-
ing of ICAM-1–induced tyrosine phosphorylation of cyto-
skeletal proteins potentially involved in the arrangement
of inter-endothelial junctions, such as cortactin and src.
More recently, the mechanisms leading to opening of en-
dothelial adherence junctions during leukocyte diapedesis
were investigated by Del Maschio et al. (1996) who did not
observe changes in the junctional structures when ICAM-1
was clustered on the endothelial surface. Ziegelstein et al.
(1994) and Pfau et al. (1995) examined the effect of anti-
CD18 mAb, and anti–ICAM-1 mAb, respectively, on
changes in endothelial [Ca21]i induced by the adherence of
leukocytes. Ziegelstein et al. (1994) found that [Ca21]i
changes induced by PMN adherence were partially
(z50%) inhibited by anti-CD18 mAb. Similarly, Pfau et
al. (1995) observed that changes in HUVEC [Ca21]i
caused by the adherence of natural killer lymphocytes
were partially inhibited by an anti–ICAM-1 mAb. In the
present study, we observed some degree of inhibition of
the changes in HUVEC [Ca21]i induced by leukocytes by
anti–ICAM-1 mAb only when PMN were added to hista-
mine-stimulated HUVEC. However, the inhibition was
weak and inconsistent, and did not achieve statistical sig-
nificance. It should be noted that leukocytes treated with
anti-sLex and/or anti–VLA-4 mAb were unable to induce
endothelial [Ca21]i changes or stress fibers formation,
even though CD11a/CD18 and CD11b/CD18 were free to
interact with endothelial ICAM-1. From this result we sug-
gest that the interaction of leukocyte CD11/CD18 with en-
dothelial ICAM-1 acts primarily as a co-stimulus for en-
dothelial [Ca21]i changes.
Formation of stress fibers was described in ECs under-
going mechanical stress (Sato and Ohshima, 1994; Cucina
et al., 1995), or ECs exposed to soluble inflammatory ago-
nists, such as histamine and thrombin (Rotrosen and Gal-
lin, 1986; Kolodney and Wysolmerski, 1992). A novel find-
ing in the present study is that PMN or monocyte
adherence also induces rearrangements of endothelial ac-
tin filaments, leading to formation of stress fibers. Gross
changes in endothelial morphology were described to oc-
cur during leukocyte adherence to and passage across the
endothelial lining of blood vessels (Marchesi and Florey,
1960). More recently, Hixenbaugh et al. (1997) demon-
strated that neutrophil adhesion to HUVEC induces en-
dothelial myosin light chain phosphorylation and contrac-
tion of the monolayers. However, the mechanism(s) by
which adhering leukocytes induce endothelial contraction
have not been well characterized. Our evidence linking ad-
hesion receptors, [Ca21]i changes, and formation of stress
fibers contributes to our understanding of these mecha-
nisms.
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Table IV. Effect of mAb to Leukocyte Adhesion Molecules on Leukocyte-induced Changes in HUVEC F-Actin Morphology
Stress fiber–positive HUVEC (%)
PMN treatment Medium (control) CSLEX1 (anti-sLex) 60.3 (anti-CD18) M89D3 (anti–PECAM-1)
LPS-treated HUVEC (5 h) 64.3 6 5.8 16.7 6 2.5* 58.4 6 6.1 60.9 6 6.6
Monocyte treatment Medium (control) CSLEX1 (anti-sLex) 60.3 (anti-CD18) M89D3 (anti–PECAM-1) HP2/1 (anti-VLA-4)
LPS-treated HUVEC (24 h) 61.3 6 4.4 56.2 6 3.7 68.3 6 4.6 71.2 6 7.1 20.1 6 2.1*
Before the assay, HUVEC monolayers were treated for 5 or 24 h with 0.5 mg/ml E. coli LPS. Leukocytes (PMN or monocytes) were treated for 60 min in the presence or absence
of mAb CSLEX1, mAb 60.3, mAb M89D3, or mAb HP2/1 (20 mg/ml). Leukocytes were then added to the monolayers (leukocyte/HUVEC ratio 5 6–8:1) and the cells were incu-
bated for 10 min at 37°C. The monolayers were then fixed and stained for F-actin. Coverslips were analyzed for HUVEC actin distribution by two observers. An average of 300–
400 cells were examined on each coverslip. Values are means 6 SE of three experiments. *P , 0.05 (paired t test) compared to controls.Lorenzon et al. Outside-In Signaling by Endothelial Adherence Molecules 1391
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